Cefepime versus ceftriaxone for empiric treatment of hospitalized patients with community-acquired pneumonia

被引：1
|
作者：
Borja, J [1 ]
Jané, F [1 ]
机构：
[1] Hosp Santa Creu & St Pau, Dept Clin Pharmacol, Barcelona 08025, Spain
来源：
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 1999年 / 43卷 / 02期
关键词：
D O I：
10.1128/AAC.43.2.436
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
引用
收藏
页码：436 / 436
页数：1
相关论文
共 50 条
  • [41] Effect of macrolides as part of initial empiric therapy on length of stay in patients hospitalized with community-acquired pneumonia
    Stahl, JE
    Barza, M
    DesJardin, J
    Martin, R
    Eckman, MH
    ARCHIVES OF INTERNAL MEDICINE, 1999, 159 (21) : 2576 - 2580
  • [42] Etiology of community-acquired pneumonia in hospitalized patients in Jordan
    Al-Ali, Musa K.
    Batchoun, Raymond G.
    Al-Nour, Tarig M.
    SAUDI MEDICAL JOURNAL, 2006, 27 (06) : 813 - 816
  • [43] PREDICTING DEATH IN PATIENTS HOSPITALIZED FOR COMMUNITY-ACQUIRED PNEUMONIA
    FARR, BM
    SLOMAN, AJ
    FISCH, MJ
    ANNALS OF INTERNAL MEDICINE, 1991, 115 (06) : 428 - 436
  • [44] Hantavirus serologies in patients hospitalized with community-acquired pneumonia
    Auwaerter, PG
    Oldach, D
    Mundy, LM
    Burton, A
    Warner, ML
    Vance, E
    Moore, RD
    Rossi, CA
    JOURNAL OF INFECTIOUS DISEASES, 1996, 173 (01): : 237 - 239
  • [45] Multimarker Prognostication for Hospitalized Patients with Community-acquired Pneumonia
    Lee, So Yeon
    Cha, Seung-Ick
    Seo, Hyewon
    Oh, Serim
    Choi, Keum-Ju
    Yoo, Seung-Soo
    Lee, Jaehee
    Lee, Shin-Yup
    Kim, Chang-Ho
    Park, Jae-Yong
    INTERNAL MEDICINE, 2016, 55 (08) : 887 - 893
  • [46] Empiric oral monotherapy for hospitalized patients with community-acquired pneumonia: An idea whose time has come
    Cunha, BA
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2004, 23 (02) : 78 - 81
  • [47] Levofloxacin versus ceftriaxone and intravenous amoxicillin/clavulanate in the treatment of community-acquired pneumonia that require hospitalization
    Kalbermatter, V
    Bagilet, D
    Diab, M
    Javkin, E
    MEDICINA CLINICA, 2000, 115 (15): : 561 - 563
  • [48] Levofloxacin versus ceftriaxone plus clarithromycin in the treatment of adults with community-acquired pneumonia requiring hospitalization
    Querol-Ribelles, JM
    Tenías, JM
    Querol-Borrás, JM
    Labrador, T
    Nieto, A
    González-Granda, D
    Martínez, I
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2005, 25 (01) : 75 - 83
  • [49] Cost-effectiveness of ceftriaxone in the treatment of community-acquired pneumonia in adult hospital patients
    Barker, J
    Patrick, H
    Badenhorst, C
    SOUTH AFRICAN MEDICAL JOURNAL, 1998, 88 (09): : 1048 - +
  • [50] Cefuroxime for Empiric Treatment of Community-Acquired Pneumococcal Pneumonia: Is There a Generation Gap?
    Wiener-Well, Yonit
    Raveh, David
    Schlesinger, Yechiel
    Yinnon, Amos M.
    Rudensky, Bernard
    CHEMOTHERAPY, 2009, 55 (02) : 97 - 104
12345